stockrowGuardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.
- Revenue
- +36.1%
- EPS
- −25.7%
- Free cash flow
- +18.7%
- Total debt
- +34.8%
Quarter to September 2026, against a year earlier
Follow GH
Alert me
Guardant Health, Inc. (GH) Return on invested capital
Guardant Health, Inc.'s return on invested capital over the twelve months to 30 September 2026 was −25.7%, up 108.9 percentage points from fiscal 2025 (−134.6%). Over the past ten years it has ranged from −271.5% (fiscal 2023) to 0.00% (fiscal 2016); the current reading is higher than 40% of that period. That is below the Diagnostics & Research industry median of 0.00% and below the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | −134.6% | 35.61 |
| FY2024 | −170.2% | 101.30 |
| FY2023 | −271.5% | (88.88) |
| FY2022 | −182.6% | (152.27) |
| FY2021 | −30.3% | 21.10 |
| FY2020 | −51.4% | (35.11) |
| FY2019 | −16.3% | 65.29 |
| FY2018 | −81.6% | (27.03) |
| FY2017 | −54.6% | (54.57) |
| FY2016 | 0.00% | — |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| MTD Mettler-Toledo International, Inc. compare | 35.4% |
| ILMN Illumina, Inc. compare | 16.7% |
| DGX Quest Diagnostics Incorporated compare | 8.48% |
| LH Labcorp Holdings Inc. compare | 6.76% |
| ICLR ICON PLC compare | 3.84% |
| RVTY Revvity Inc. compare | 2.50% |
| CRL Charles River Laboratories International, Inc. compare | 1.81% |
| MEDP Medpace Holdings, Inc. compare | 0.00% |
| GH Guardant Health, Inc. | −25.7% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on GH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement